Real-life indications to sacubitril/valsartan treatment in patients with chronic systolic heart failure
Objective: International guidelines recommend the introduction of sacubitril/valsartan
(Entresto) in patients with heart failure (HF) and reduced ejection fraction (EF), who remain …
(Entresto) in patients with heart failure (HF) and reduced ejection fraction (EF), who remain …
Real-Life Indications to Sacubitril/Valsartan Treatment in Patients with Chronic Systolic Heart Failure
G Pinto, L Tondi, M Gemma, A De Marco… - JOURNAL OF …, 2019 - iris.unisr.it
Objective: International guidelines recommend the introduction of sacubitril/valsartan
(Entresto) in patients with heart failure (HF) and reduced ejection fraction (EF), who remain …
(Entresto) in patients with heart failure (HF) and reduced ejection fraction (EF), who remain …
Real-Life Indications to Sacubitril/Valsartan Treatment in Patients With Chronic Systolic Heart Failure
G Pinto, L Tondi, M Gemma… - Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective International guidelines recommend the introduction of sacubitril/valsartan
(Entresto) in patients with heart failure (HF) and reduced ejection fraction (EF), who remain …
(Entresto) in patients with heart failure (HF) and reduced ejection fraction (EF), who remain …
Real-Life Indications to Sacubitril/Valsartan Treatment in Patients With Chronic Systolic Heart Failure.
G Pinto, L Tondi, M Gemma, A De Marco… - Journal of …, 2019 - europepmc.org
Objective International guidelines recommend the introduction of sacubitril/valsartan
(Entresto) in patients with heart failure (HF) and reduced ejection fraction (EF), who remain …
(Entresto) in patients with heart failure (HF) and reduced ejection fraction (EF), who remain …